Author Archives: Yedida Y Bogachkov PhD

Jasper Therapeutics, Avrobio Team Up to Assess JSP191

Jasper Therapeutics and Avrobio have entered into a non-exclusive research collaboration to evaluate the use of JSP191 in patients with Fabry disease who are being treated with one of Avrobio’s investigational gene therapies. Under this collaboration, JSP191 — an anti-CD117 monoclonal antibody — also will be…